New data backs Transgene’s lung cancer vaccine
September 15th, 2008
nospam@example.com (Clear the Smoke) wrote an interesting post today on
French biotech company Transgene said on Monday that further clinical results showed the survival benefits of its therapeutic vaccine TG4010 in treating patients with advanced non-small cell lung cancer.
Read the rest of this great post here
Posted in